Montgomery County, PA, United States of America

John F Nancarrow, Deceased

This inventor holds 1 USPTO granted patent. Top assignee: Merck + Co., Inc.. Active years: 1985.

IDiyas Innovation Intelligence. (2026). Inventor Profile: John F Nancarrow, Deceased. Retrieved from https://idiyas.com/inventor/john-f-nancarrow-deceased

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 27(Granted Patents)


Company Filing History:


Years Active: 1985

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of John F Nancarrow

Introduction

John F Nancarrow was a notable inventor whose contributions to the field of pharmaceuticals have left a lasting impact. He was particularly known for his work on indacrinone, a compound with significant therapeutic benefits. His innovative approach to balancing the properties of this compound has been recognized in the medical community.

Latest Patents

Nancarrow held a patent for indacrinone, which is described as having enhanced uricosuric properties. The patent details how the uricosuric and diuretic properties of indacrinone are carefully balanced by manipulating the proportion of (+) and (-) enantiomers within critical limits. This innovation has provided maximum therapeutic benefit for patients requiring such treatments.

Career Highlights

Throughout his career, Nancarrow worked at Merck & Co., Inc., where he made significant strides in pharmaceutical research. His dedication to improving drug efficacy and safety has been a hallmark of his professional journey. His work has contributed to advancements in the treatment of conditions related to uric acid levels.

Collaborations

Nancarrow collaborated with esteemed colleagues, including Edward H Blaine and Edward J Cragoe, Jr. These partnerships were instrumental in advancing his research and bringing innovative solutions to the pharmaceutical industry.

Conclusion

John F Nancarrow's legacy as an inventor is marked by his innovative work on indacrinone and his contributions to pharmaceutical research. His efforts have had a profound impact on therapeutic practices, and his work continues to be recognized in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…